<p><u><b>a</b></u>. Three-fold decreasing doses of TNP Ts Sup-derived PCE regressively suppresses adoptive CS responses down to a dose of 15μg per eventual recipient (Groups B and C). <u><b>b</b></u>. Five-fold decreasing dose-response of QRNA from TNP Ts Sup PCE results in suppression of adoptive CS responses down to a dose of 0.6μg per recipient (Group C).</p
<p>CD4+ naïve T cells were isolated and CFSE labeled. Unlabeled control T<sub>M</sub> or Tregs were ...
<p>(A) Experimental setup: siRNA transfection of iTreg cells. (B) On day 3 of differentiation cultur...
<p>The schematic illustrates the potential mechanism of CPPP in treatment of TKI-sensitive and -resi...
<p><u><b>a</b></u><b>.</b> PCE from TNP Ts Sup suppresses the adoptive transfer of CS-effector cells...
<p><u><b>a</b></u>. TNP Ts Sup-derived PCE suppression is sensitive to RNase A (Sigma 4375), but not...
<p><u><b>a.</b></u> Treatment of TNP-CS-effector cells with two day immune B-1 B cell-derived TNP-sp...
<p><u><b>a</b></u>. Treatment of CS-effector cells from either wild type (WT) or TLR3<sup>-/-</sup> ...
<p>(A) and (B) Down-regulation of SENP1, c-Jun or AR expression increased cell viability upon Tripto...
<p>PBT cells from healthy nonsmokers (<b>A</b>) or patients with SCOPD (<b>B</b>) were cultured and ...
<p>(A) Real time RT-PCR analysis of TrKA<sup>NTR</sup> and p75<sup>NTR</sup> mRNA treated for 24h wi...
<p>(<b>A</b>) A total of 1×10<sup>6</sup> CFSE labeled splenocytes from a Rag1<sup>−/−</sup>OT-II mo...
<p><b>A</b>. Human CASMC were transfected with either scrambled negative control siRNA (siNeg) or wi...
<p>NE and IFN-γ affect proliferation (OD 490 nm) and invasion (OD 570 nm) of MIA PaCa-2 (A and B) an...
<p>(<b>A</b>) Immunostaining for PSA-NCAM and NCAM in TCE treated and untreated C6 cells (Scale bar-...
<p>RAW 264.7 mock infected (RAW), non-specific shRNA (control), and MyD88 specific shRNA (MyD88), an...
<p>CD4+ naïve T cells were isolated and CFSE labeled. Unlabeled control T<sub>M</sub> or Tregs were ...
<p>(A) Experimental setup: siRNA transfection of iTreg cells. (B) On day 3 of differentiation cultur...
<p>The schematic illustrates the potential mechanism of CPPP in treatment of TKI-sensitive and -resi...
<p><u><b>a</b></u><b>.</b> PCE from TNP Ts Sup suppresses the adoptive transfer of CS-effector cells...
<p><u><b>a</b></u>. TNP Ts Sup-derived PCE suppression is sensitive to RNase A (Sigma 4375), but not...
<p><u><b>a.</b></u> Treatment of TNP-CS-effector cells with two day immune B-1 B cell-derived TNP-sp...
<p><u><b>a</b></u>. Treatment of CS-effector cells from either wild type (WT) or TLR3<sup>-/-</sup> ...
<p>(A) and (B) Down-regulation of SENP1, c-Jun or AR expression increased cell viability upon Tripto...
<p>PBT cells from healthy nonsmokers (<b>A</b>) or patients with SCOPD (<b>B</b>) were cultured and ...
<p>(A) Real time RT-PCR analysis of TrKA<sup>NTR</sup> and p75<sup>NTR</sup> mRNA treated for 24h wi...
<p>(<b>A</b>) A total of 1×10<sup>6</sup> CFSE labeled splenocytes from a Rag1<sup>−/−</sup>OT-II mo...
<p><b>A</b>. Human CASMC were transfected with either scrambled negative control siRNA (siNeg) or wi...
<p>NE and IFN-γ affect proliferation (OD 490 nm) and invasion (OD 570 nm) of MIA PaCa-2 (A and B) an...
<p>(<b>A</b>) Immunostaining for PSA-NCAM and NCAM in TCE treated and untreated C6 cells (Scale bar-...
<p>RAW 264.7 mock infected (RAW), non-specific shRNA (control), and MyD88 specific shRNA (MyD88), an...
<p>CD4+ naïve T cells were isolated and CFSE labeled. Unlabeled control T<sub>M</sub> or Tregs were ...
<p>(A) Experimental setup: siRNA transfection of iTreg cells. (B) On day 3 of differentiation cultur...
<p>The schematic illustrates the potential mechanism of CPPP in treatment of TKI-sensitive and -resi...